Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma.
Chang KP, Tsang NM, Liao CT, Hsu CL, Chung MJ, Lo CW, Chan SC, Ng SH, Wang HM, Yen TC.
J Nucl Med. 2012 Jan;53(1):21-8. Erratum in: J Nucl Med. 2012 Feb;53(2):342.
Related citations
Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.
Hatt M, Le Pogam A, Visvikis D, Pradier O, Cheze Le Rest C.
J Nucl Med. 2012 Jan;53(1):12-20.
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Kauhanen S, Schalin-Jäntti C, Seppänen M, Kajander S, Virtanen S, Schildt J, Lisinen I, Ahonen A, Heiskanen I, Väisänen M, Arola J, Korsoff P, Ebeling T, Sane T, Minn H, Välimäki MJ, Nuutila P.
J Nucl Med. 2011 Dec;52(12):1855-63. Epub 2011 Nov 3.
General nuclear medicine.
Ziessman HA.
J Nucl Med. 2011 Nov;52(11):20N-8N. No abstract available.
Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.
Kim JE, Ahn BC, Hwang MH, Jeon YH, Jeong SY, Lee SW, Lee J.
J Nucl Med. 2011 Nov;52(11):1756-63. Epub 2011 Oct 12.
89Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: preclinical results.
Heuveling DA, Visser GW, Baclayon M, Roos WH, Wuite GJ, Hoekstra OS, Leemans CR, de Bree R, van Dongen GA.
J Nucl Med. 2011 Oct;52(10):1580-4. Epub 2011 Sep 2.
First clinical evidence that imaging with somatostatin receptor antagonists is feasible.
Wild D, Fani M, Behe M, Brink I, Rivier JE, Reubi JC, Maecke HR, Weber WA.
J Nucl Med. 2011 Sep;52(9):1412-7. Epub 2011 Aug 18.
The Japanese tsunami and resulting nuclear emergency at the Fukushima Daiichi power facility: technical, radiologic, and response perspectives.
Dauer LT, Zanzonico P, Tuttle RM, Quinn DM, Strauss HW.
J Nucl Med. 2011 Sep;52(9):1423-32. Epub 2011 Jul 28.
(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
zum Büschenfelde CM, Herrmann K, Schuster T, Geinitz H, Langer R, Becker K, Ott K, Ebert M, Zimmermann F, Friess H, Schwaiger M, Peschel C, Lordick F, Krause BJ.
J Nucl Med. 2011 Aug;52(8):1189-96. Epub 2011 Jul 15.
The need for a low-expense universally acceptable rhTSH protocol.
Ora M, P M, Jain S, Barai S, Gambhir S.
J Nucl Med. 2011 Jul;52(7):1166. Epub 2011 Jun 16. No abstract available.
Correlation of 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer.
Choi SH, Paeng JC, Sohn CH, Pagsisihan JR, Kim YJ, Kim KG, Jang JY, Yun TJ, Kim JH, Han MH, Chang KH.
J Nucl Med. 2011 Jul;52(7):1056-62. Epub 2011 Jun 16.
The real cost of theoretic risk avoidance: the need to challenge unsubstantiated concerns about (131)I therapy.
Goldsmith SJ.
J Nucl Med. 2011 May;52(5):681-2. Epub 2011 Apr 15. No abstract available. Erratum in: J Nucl Med. 2011 Jun;52(6):993.
Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases.
Higashi T, Nishii R, Yamada S, Nakamoto Y, Ishizu K, Kawase S, Togashi K, Itasaka S, Hiraoka M, Misaki T, Konishi J.
J Nucl Med. 2011 May;52(5):683-9. Epub 2011 Apr 15.
Molecular imaging in radiotherapy planning for head and neck tumors.
Grégoire V, Chiti A.
J Nucl Med. 2011 Mar;52(3):331-4. Epub 2011 Feb 14.
Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT.
Wu HB, Wang QS, Wang MF, Zhen X, Zhou WL, Li HS.
J Nucl Med. 2011 Mar;52(3):341-6. Epub 2011 Feb 14.
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
Tixier F, Le Rest CC, Hatt M, Albarghach N, Pradier O, Metges JP, Corcos L, Visvikis D.
J Nucl Med. 2011 Mar;52(3):369-78. Epub 2011 Feb 14.
PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity.
Liao CT, Wang HM, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Ng SH, Hsueh C, Lee LY, Lin CH, Yen TC.
J Nucl Med. 2011 Feb;52(2):180-7.
Metabolic imaging allows early prediction of response to vandetanib.
Walter MA, Benz MR, Hildebrandt IJ, Laing RE, Hartung V, Damoiseaux RD, Bockisch A, Phelps ME, Czernin J, Weber WA.
J Nucl Med. 2011 Feb;52(2):231-40. Epub 2011 Jan 13.
The role of routine diagnostic radioiodine whole-body scintigraphy in patients with high-risk differentiated thyroid cancer.
de Meer SG, Vriens MR, Zelissen PM, Borel Rinkes IH, de Keizer B.
J Nucl Med. 2011 Jan;52(1):56-9. Epub 2010 Dec 13.
Patient release issue reopened.
[No authors listed]
J Nucl Med. 2010 Dec;51(12):13N. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on